BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Neuron
,
Avian flu virus
,
Aspirin
,
rs6983267
,
MDM2
,
glucose metabolic process
,
Ischemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
insulin- receptor
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
The insulin receptor discovery is 50 years old - A review of achieved progress].
The P300 acetyltransferase inhibitor C646 promotes membrane translocation of insulin receptor protei…
The serine phosphorylations in the IRS-1 PIR domain abrogate IRS-1 and IR interaction.
Phosphorylation of insulin receptor substrates (IRS-1 and IRS-2) is attenuated following cecal ligat…
High risk genetic variants of human insulin receptor substrate 1(IRS1) infer structural instability …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Thyroid Hormone to Induce Non-Insulin Mediated Glucose Disposal in People With Insulin Receptor Muta…
Interleukin-1 Receptor Antagonist and Insulin Sensitivity
The Suppression of Toll Like Receptors by Insulin
Safety and Dose Ranging Study of Insulin Receptor MAb-IDUA Fusion Protein in Patients With MPS I
Role of AT1-receptor Blockers in Insulin-induced Vasodilation.
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ